Bococizumab is a novel anti-PCSK9 antibody efficiently developed to combat hypercholesterolemia. It therapeutic agent interacts with the PCSK9 protein, a essential regulator of cholesterol levels. By neutralizing the https://dirstop.com/story27994678/bococizumab-a-novel-anti-pcsk9-antibody-for-hypercholesterolemia